{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T17:58:38Z","timestamp":1761933518938,"version":"build-2065373602"},"reference-count":21,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2012,1,17]],"date-time":"2012-01-17T00:00:00Z","timestamp":1326758400000},"content-version":"vor","delay-in-days":4186,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[2000,8]]},"abstract":"<jats:p>The objective of this survey of primary care physicians in Salt Lake County, Utah, was to determine how many of these providers were prescribing anorexigenics (antiobesity drugs) and to evaluate their knowledge of side effects and drug interactions. A confidential survey was sent to 377 family practice, internal medicine, and obstetrics\u2010gynecology physicians, of whom 236 (62.5%) responded. Of those who answered the survey completely, 146 (65.2%) prescribed anorexigenics to 5107 patients. Family practice physicians, male physicians less than 40 years old, and internal medicine physicians less than 40 years old prescribed anorexigenics more frequently than their counterparts. Female physicians (vs male) and female family practice physicians (vs male family practice physicians) reported a higher proportion of psychiatric comorbidity among patients for whom they prescribed the drugs. Respondents had limited knowledge of side effects and drug interactions of anorexigenics. Better understanding of physicians' prescribing patterns of these agents is relevant for current and future optimal treatment of obesity.<\/jats:p>","DOI":"10.1592\/phco.20.11.967.35267","type":"journal-article","created":{"date-parts":[[2004,6,17]],"date-time":"2004-06-17T06:11:55Z","timestamp":1087452715000},"page":"967-973","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Physician Prescribing of Anorexigenics for Weight Loss in Salt Lake County, Utah"],"prefix":"10.1002","volume":"20","author":[{"given":"Christopher","family":"Gay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Shane\u2010McWhorter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathy","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Bishop","family":"Stone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,1,17]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8223(97)00024-2"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-119-7_Part_2-199310011-00006"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.16.1523"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.16.1530"},{"key":"e_1_2_1_6_2","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1001\/jama.1993.03510180077038","article-title":"Actual causes of death in the United States","volume":"270","author":"McGinnis JM","year":"1993","journal-title":"JAMA"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-199400051-00007"},{"key":"e_1_2_1_8_2","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1001\/jama.1996.03540230057036","article-title":"Long\u2010term pharmacotherapy in the management of obesity","volume":"276","author":"National Task Force on the Prevention and Treatment of Obesity","year":"1996","journal-title":"JAMA"},{"issue":"2","key":"e_1_2_1_9_2","first-page":"51S","article-title":"Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults\u2014the evidence report","volume":"6","author":"National Heart, Lung, and Blood Institute Obesity Task Force","year":"1998","journal-title":"Obesity Res"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-119-7_Part_2-199310011-00016"},{"key":"e_1_2_1_11_2","first-page":"1061","article-title":"Cardiac valvulopathy associated with exposure to fenfluramine or dexfenfluramine","volume":"46","author":"Centers for Disease Control and Prevention","year":"1997","journal-title":"MMWR"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1992.68"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199708283370901"},{"volume-title":"Recommendations for patients who have used anorectic drugs","year":"1997","author":"American College of Cardiology","key":"e_1_2_1_14_2"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199809103391101"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199809103391103"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199809103391102"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199608293350901"},{"key":"e_1_2_1_19_2","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0022-3565(25)38720-3","article-title":"Dexfenfluramine and serotonin neurotoxicity: further clinical evidence that clinical caution is indicated","volume":"269","author":"McCann U","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.22.6.896"},{"key":"e_1_2_1_21_2","unstructured":"Knoll Pharmaceutical Company.Meridia (sibutramine) product information. Mount Olive NJ;1997."},{"key":"e_1_2_1_22_2","unstructured":"Roche Laboratories.Xenical (orlistat) product information. Nutley NJ;1999."}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1592%2Fphco.20.11.967.35267","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1592\/phco.20.11.967.35267","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:55:39Z","timestamp":1761054939000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1592\/phco.20.11.967.35267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2000,8]]}},"alternative-id":["10.1592\/phco.20.11.967.35267"],"URL":"https:\/\/doi.org\/10.1592\/phco.20.11.967.35267","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"type":"print","value":"0277-0008"},{"type":"electronic","value":"1875-9114"}],"subject":[],"published":{"date-parts":[[2000,8]]},"assertion":[{"value":"2012-01-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}